Trials / Completed
CompletedNCT03596242
SMS System for Patients With Uncontrolled Hypertension
Short Message Service System for Patients With Uncontrolled Hypertension
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- Wake Forest University Health Sciences · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a pilot study to determine the potential of utilizing Short Message Service (SMS) messaging to improve health outcomes for patients with uncontrolled hypertension receiving care from the Outpatient Internal Medicine Clinic at Wake Forest Baptist Hospital.
Detailed description
The pilot will evaluate the feasibility of implementing a Short Message Service (SMS) system and Home Blood Pressure Measurements (HBPM) in the Outpatient Internal Medicine (OPD) clinic at Wake Forest Baptist Hospital. Implementing a new short text messaging service will improve the health delivery system in three ways. 1) Increasing patient engagement: SMS and HBPM require an active commitment by the patients themselves in their medical care and results in a marked improvement in the adherence to medication. High adherence to home blood pressure (BP) measurements has also been reported to improve BP control. 2) Supporting patients outside of the office visits by identifying and resolving barriers to medication adherence earlier on (i.e. if patients are unable to get their prescriptions or are having significant side effects). 3) Adopting clinical guidelines to improve BP control in a vulnerable population.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | SMS System | Participants will receive usual care +SMS texting and phone calls to monitor their blood pressure and medication adherence |
| BEHAVIORAL | blood pressure control education | standard blood pressure control education given during visits |
Timeline
- Start date
- 2021-03-09
- Primary completion
- 2021-12-06
- Completion
- 2021-12-06
- First posted
- 2018-07-23
- Last updated
- 2023-09-28
- Results posted
- 2023-09-28
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03596242. Inclusion in this directory is not an endorsement.